Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  IDH1R132H-specific peptide vaccine PEPIDH1M
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Vaccine Therapy and Temozolomide in Treating Patients with Recurrent Glioma Expressing IDH1
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Pro00054746, NCI-2015-02213, NCT02193347
Start Over